Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Exp Eye Res ; 243: 109890, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38615833

ABSTRACT

Phosphodiesterase (PDE) inhibitors - such as vardenafil - are used primarily for treating erectile dysfunction via increasing cyclic guanosine monophosphate (cGMP) levels. Recent studies have also demonstrated their significant cardioprotective effects in several diseases, including diabetes, upon long-term, continuous application. However, PDE inhibitors are not specific for PDE5 and also inhibit the retinal isoform. A sustained rise in cGMP in photoreceptors is known to be toxic; therefore, we hypothesized that long-term vardenafil treatment might result in retinotoxicity. The hypothesis was tested in a clinically relevant animal model of type 2 diabetes mellitus. Histological experiments were performed on lean and diabetic Zucker Diabetic Fatty rats. Half of the animals were treated with vardenafil for six months, and the retinal effects were evaluated. Vardenafil treatment alleviated rod outer segment degeneration but decreased rod numbers in some positions and induced changes in the interphotoreceptor matrix, even in control animals. Vardenafil treatment decreased total retinal thickness in the control and diabetic groups and reduced the number of nuclei in the outer nuclear layer. Müller cell activation was detectable even in the vardenafil-treated control animals, and vardenafil did not improve gliosis in the diabetic group. Vardenafil-treated animals showed complex retinal alterations with improvements in some parameters while deterioration in others. Our results point towards the retinotoxicity of vardenafil, even without diabetes, which raises doubts about the retinal safety of long-term continuous vardenafil administration. This effect needs to be considered when approving PDE inhibitors for alternative indications.


Subject(s)
Diabetes Mellitus, Experimental , Phosphodiesterase 5 Inhibitors , Rats, Zucker , Vardenafil Dihydrochloride , Vardenafil Dihydrochloride/pharmacology , Vardenafil Dihydrochloride/toxicity , Animals , Rats , Phosphodiesterase 5 Inhibitors/pharmacology , Male , Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Type 2/drug therapy , Diabetic Retinopathy/drug therapy , Diabetic Retinopathy/pathology , Retina/drug effects , Retina/pathology , Ependymoglial Cells/drug effects , Ependymoglial Cells/pathology , Ependymoglial Cells/metabolism
2.
Klin Monbl Augenheilkd ; 241(4): 533-537, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38653305

ABSTRACT

Electroretinography (ERG) provides crucial insights into retinal function and the integrity of the visual pathways. However, ERG assessments classically require a complicated technical background with costly equipment. In addition, the placement of corneal or conjunctival electrodes is not always tolerated by the patients, which restricts the measurement for pediatric evaluations. In this short review, we give an overview of the use of the RETeval portable ERG device (LKC Technologies, Inc., Gaithersburg, MD, USA), a modern portable ERG device that can facilitate screening for diseases involving the retina and the optic nerve. We also review its potential to provide ocular biomarkers in systemic pathologies, such as Alzheimer's disease and central nervous system alterations, within the framework of oculomics.


Subject(s)
Electroretinography , Equipment Design , Retinal Diseases , Humans , Electroretinography/instrumentation , Electroretinography/economics , Retinal Diseases/diagnosis , Equipment Failure Analysis , Miniaturization , Reproducibility of Results , Sensitivity and Specificity , Mass Screening/instrumentation , Mass Screening/economics , Vision Screening/instrumentation , Vision Screening/economics , Health Care Costs
3.
Klin Monbl Augenheilkd ; 241(4): 489-495, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38653299

ABSTRACT

PURPOSE: To evaluate the efficacy of a subthreshold micropulse laser (SML) in patients with central serous chorioretinopathy (CSCR). METHODS: Retrospective clinical study conducted at the Departments of Ophthalmology at a university and a municipal hospital in Zurich, Switzerland. We enrolled acute and chronic CSCR patients with persistent subretinal fluid (SRF) treated with SML. Two treatment protocols (fluorescein/indocyanine green angiography or optical coherence tomography guided) were evaluated for efficacy after 3 and 6 months. The primary outcomes of the study were reduction and percentage of eyes with complete resolution of SRF 3 and 6 months after SML treatment. Secondary endpoints included changes in central subfield thickness (CST) and visual acuity (VA) after 3 and 6 months. RESULTS: The study involved 37 eyes (35 patients, 48.6% chronic). A statistically significant reduction in SRF height and CST could be shown, irrespective of SRF duration, type of CSCR, or chosen guidance after 3 and 6 months: SRF - 40 µm (p < 0.01), CST - 52 µm (p < 0.01). Percentage of eyes with complete resolution of fluid at 3 and 6 months after SML were 24.3 and 21.6%, respectively. No statistically significant functional improvement (VA) could be shown. Multivariable regression and linear mixed regression analyses did not identify statistically significant differences in SRF reduction, CMT change, or VA improvement with respect to the type of CSCR or the treatment plan used (p > 0.05). CONCLUSION: The effectiveness of SML in CSCR is under continuous debate. Our study findings demonstrate structural but only little functional changes with SML. In view of the shortage of verteporfin for photodynamic therapy, SML remains an important therapeutic option for CSCR patients.


Subject(s)
Central Serous Chorioretinopathy , Humans , Central Serous Chorioretinopathy/surgery , Central Serous Chorioretinopathy/diagnostic imaging , Male , Female , Treatment Outcome , Middle Aged , Retrospective Studies , Adult , Visual Acuity , Laser Coagulation/methods , Aged , Subretinal Fluid
4.
Stud Health Technol Inform ; 316: 1664-1668, 2024 Aug 22.
Article in English | MEDLINE | ID: mdl-39176530

ABSTRACT

In ophthalmology, Optical Coherence Tomography (OCT) has become a daily used tool in the diagnostics and therapeutic planning of various diseases. Publicly available datasets play a crucial role in advancing research by providing access to diverse imaging data for algorithm development. The accessibility, data format, annotations, and metadata are not consistent across OCT datasets, making it challenging to efficiently use the available resources. This article provides a comprehensive analysis of different OCT datasets, with particular attention to dataset properties, disease representation, accessibility, and aims to create a catalog of all publicly available OCT datasets. The goal is to improve accessibility to OCT data, increase openness about the availability, and give important new perspectives on the state of OCT imaging resources. Our findings reveal the need for improved data-sharing practices and standardized documentation.


Subject(s)
Tomography, Optical Coherence , Humans , Retinal Diseases/diagnostic imaging , Databases, Factual , Retina/diagnostic imaging , Information Dissemination
5.
Diagnostics (Basel) ; 14(15)2024 Aug 01.
Article in English | MEDLINE | ID: mdl-39125544

ABSTRACT

Artificial intelligence has transformed medical diagnostic capabilities, particularly through medical image analysis. AI algorithms perform well in detecting abnormalities with a strong performance, enabling computer-aided diagnosis by analyzing the extensive amounts of patient data. The data serve as a foundation upon which algorithms learn and make predictions. Thus, the importance of data cannot be underestimated, and clinically corresponding datasets are required. Many researchers face a lack of medical data due to limited access, privacy concerns, or the absence of available annotations. One of the most widely used diagnostic tools in ophthalmology is Optical Coherence Tomography (OCT). Addressing the data availability issue is crucial for enhancing AI applications in the field of OCT diagnostics. This review aims to provide a comprehensive analysis of all publicly accessible retinal OCT datasets. Our main objective is to compile a list of OCT datasets and their properties, which can serve as an accessible reference, facilitating data curation for medical image analysis tasks. For this review, we searched through the Zenodo repository, Mendeley Data repository, MEDLINE database, and Google Dataset search engine. We systematically evaluated all the identified datasets and found 23 open-access datasets containing OCT images, which significantly vary in terms of size, scope, and ground-truth labels. Our findings indicate the need for improvement in data-sharing practices and standardized documentation. Enhancing the availability and quality of OCT datasets will support the development of AI algorithms and ultimately improve diagnostic capabilities in ophthalmology. By providing a comprehensive list of accessible OCT datasets, this review aims to facilitate better utilization and development of AI in medical image analysis.

6.
Transl Vis Sci Technol ; 13(8): 27, 2024 Aug 01.
Article in English | MEDLINE | ID: mdl-39141371

ABSTRACT

Purpose: Epiretinal membranes (ERM) pose a common challenge in vitreoretinal pathology, often causing vision impairment in older adults. The Preceyes Surgical System (PSS) supports the surgical removal of ERM through robot-assisted membrane peeling (RA-MP). This study compares surgical times and iatrogenic hemorrhages between manual membrane peeling (MMP) and RA-MP using PSS. Methods: Nine patients underwent RA-MP with PSS, whereas 16 patients (18 eyes) underwent MMP for comparative analysis. Surgical durations were categorized into RA-MP, manual forceps utilization in PSS surgeries (mRA-MP), and traditional MMP. Cumulative manual manipulation duration (cMMP), instrument grasps, and intraoperative hemorrhages were statistically analyzed using the Mann-Whitney U test. Results: RA-MP showed significantly longer peeling times compared to MMP (P < 0.001). Flap initiation grasps were similar between methods (P = 0.86), RA-MP demonstrated a significant reduction in peeling grasps (P = 0.01) and mean grasps per minute (P < 0.001). Although RA-MP resulted in fewer hemorrhages, the difference did not reach statistical significance relative to MMP (P = 0.08). Discussion: Although RA-MP tended to extend surgical time, it offered advantages in reducing tissue trauma and intraoperative hemorrhages. Further research is needed to explore the learning curve for novice surgeons and evaluate the safety profile of RA-MP. Translational Relevance: RA-MP may offer potential advantages over manual surgery, particularly in terms of reduced tissue trauma and intraoperative hemorrhages. Despite its longer duration compared with manual techniques, RA-MP may lead to fewer grasping maneuvers and lower rates of hemorrhages, thereby enhancing the safety and precision of vitreoretinal surgeries.


Subject(s)
Epiretinal Membrane , Operative Time , Robotic Surgical Procedures , Humans , Epiretinal Membrane/surgery , Aged , Male , Female , Robotic Surgical Procedures/methods , Robotic Surgical Procedures/adverse effects , Aged, 80 and over , Vitrectomy/methods , Vitrectomy/adverse effects , Middle Aged , Retrospective Studies , Visual Acuity
SELECTION OF CITATIONS
SEARCH DETAIL